drugset / Trial / NCT06544707
A Study Designed to Evaluate Tear Production
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate tear production following acute administration of AR-15512 ophthalmic solution 0.003% (0.003% AR-15512) in subjects with dry eye disease (DED).
Timeline
- Start
- 2024-10-15
- Primary completion
- 2025-01-30
- Completion
- 2025-01-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Acoltremon | Small molecule | 0.003 % | Topical |